333

PHARMSVILLE

No trades
See on Supercharts
Market capitalization
‪52.81 B‬KRW
‪3.31 B‬KRW
‪21.39 B‬KRW
‪2.04 M‬
Beta (1Y)
0.14

About PHARMSVILLE

CEO
Byeong-Wuk Lee
Headquarters
Seoul
Employees (FY)
38
Founded
2000
ISIN
KR7318010006
FIGI
BBG00Q692Z06
Pharmsville Co., Ltd. engages in the distribution of food for diet and other nutritional supplements. The company was founded on March 15, 2000 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 318010 is 6690 KRW — it has increased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMSVILLE stocks are traded under the ticker 318010.
318010 stock is 1.36% volatile and has beta coefficient of 0.14. Check out the list of the most volatile stocks — is PHARMSVILLE there?
Yes, you can track PHARMSVILLE financials in yearly and quarterly reports right on TradingView.
318010 stock has fallen by 1.62% compared to the previous week, the month change is a 2.90% fall, over the last year PHARMSVILLE has showed a 28.30% decrease.
318010 net income for the last quarter is ‪288.00 M‬ KRW, while the quarter before that showed ‪970.30 M‬ KRW of net income which accounts for −70.32% change. Track more PHARMSVILLE financial stats to get the full picture.
Today PHARMSVILLE has the market capitalization of ‪51.54 B‬, it has decreased by 0.43% over the last week.
Yes, 318010 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.50%. Tracking PHARMSVILLE dividends might help you take more informed decisions.
PHARMSVILLE dividend yield was 1.16% in 2023, and payout ratio reached 23.66%. The year before the numbers were 0.92% and 19.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 318010 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMSVILLE stock right from TradingView charts — choose your broker and connect to your account.
318010 reached its all-time high on Feb 18, 2022 with the price of 19850 KRW, and its all-time low was 6420 KRW and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 38.00 employees. See our rating of the largest employees — is PHARMSVILLE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMSVILLE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMSVILLE stock shows the sell signal. See more of PHARMSVILLE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMSVILLE EBITDA is ‪2.47 B‬ KRW, and current EBITDA margin is 10.43%. See more stats in PHARMSVILLE financial statements.